BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12757389)

  • 1. Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.
    Bagot-Guéret C; Le Bas MD; Tymciu S; Darabantu M; Emond P; Guilloteau D; Lasne MC; Wijkhuisen A; Barré L; Perrio C
    Bioconjug Chem; 2003; 14(3):629-41. PubMed ID: 12757389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel fluoro and iodo quinoline carboxamides as potential ligands of NK-3 receptors for in vivo imaging studies.
    Bennacef I; Tymciu S; Dhilly M; Lasne MC; Debruyne D; Perrio C; Barré L
    Bioorg Med Chem; 2004 Aug; 12(16):4533-41. PubMed ID: 15265501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
    Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
    J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
    Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
    Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors.
    Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F
    Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors.
    Ferrarini PL; Calderone V; Cavallini T; Manera C; Saccomanni G; Pani L; Ruiu S; Gessa GL
    Bioorg Med Chem; 2004 Apr; 12(8):1921-33. PubMed ID: 15051060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET.
    Bennacef I; Haile CN; Schmidt A; Koren AO; Seibyl JP; Staley JK; Bois F; Baldwin RM; Tamagnan G
    Bioorg Med Chem; 2006 Nov; 14(22):7582-91. PubMed ID: 16908169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
    Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
    Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists.
    Manera C; Benetti V; Castelli MP; Cavallini T; Lazzarotti S; Pibiri F; Saccomanni G; Tuccinardi T; Vannacci A; Martinelli A; Ferrarini PL
    J Med Chem; 2006 Oct; 49(20):5947-57. PubMed ID: 17004710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis.
    Blomqvist G
    Wien Klin Wochenschr; 1991; 103(15):451-7. PubMed ID: 1926871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety.
    Giuliani G; Cappelli A; Matarrese M; Masiello V; Turolla EA; Monterisi C; Fazio F; Anzini M; Pericot Mohr G; Riitano D; Finetti F; Morbidelli L; Ziche M; Giorgi G; Vomero S
    Bioorg Med Chem; 2011 Apr; 19(7):2242-51. PubMed ID: 21421318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
    Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4819-23. PubMed ID: 16139501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
    Neumeyer JL; Zhang A; Xiong W; Gu XH; Hilbert JE; Knapp BI; Negus SS; Mello NK; Bidlack JM
    J Med Chem; 2003 Nov; 46(24):5162-70. PubMed ID: 14613319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategy for development of imaging biomarkers].
    Ishiwata K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.